Pancreatic ductal adenocarcinoma (PDAC) is a significant cause of cancer de
ath worldwide. PDAC is also one of the best-studied cancers with regard to
molecular pathogenesis. The chief risk factors associated with PDAC are smo
king and pancreatitis, in addition genetic predisposition seems to play a m
ajor role. This genetic predisposition may in some cases be indirect, for e
xample via the elevated risk of pancreatitis seen in patients with heredita
ry pancreatitis (HP). The elucidation of the molecular causes of PDAC has e
nabled the provision of secondary screening for PDAC in conditions such as
HP. This review is concerned with the molecular pathogenesis of PDAC and th
e application of this basic scientific understanding into state-of-the-art
clinical practice. (C) 2001 Elsevier Science Ltd. All rights reserved.